Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Loblaw CEO, Per Bank, says company is seeking alternative suppliers to U.S. products that account for ‘less than 10 per cent’ of the company’s costs.

A lawsuit by three nonprofit s argues that executive orders from President Trump limit the ability to provide health and ...

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Publicly traded REITs remain optimistic in the face of potential widespread cuts to federal leasing at the hands of the ...

Q4 2024 Management View The CEO highlighted that 2024 ended with SUBLOCADE achieving 20% net revenue growth despite challenges, including competition in the U.S. long-acting injectable (LAI) market ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

The Northern Kentucky Chamber of Commerce (NKY Chamber) presented the NKY Community Award to Boone County Sheriff Mike Helmig ...